NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

The investigation concerns whether Hims and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

On July 29, 2026, the Federal Trade Commission ("FTC") filed a lawsuit against Hims, accusing it of sharing customers' medical information with third-party advertisers.  The FTC's criminal complaint accuses Hims of "deceptive and unlawful privacy practices," including sharing sensitive details about patient health with Meta Platforms, Snap and Facebook's parent company. 

On this news, Hims' stock price fell $4.32 per share, or 14.73%, to close at $25.00 per share on July 29, 2026. 

Then, on August 21, 2026, Bloomberg reported that Hims was put on notice by Visa Inc. for excessive customer complaints in its weight-loss subscription business, according to internal documents, adding to mounting scrutiny of its billing and cancellation policies.  Reportedly, the Company was enrolled in Visa's Acquirer Monitoring Program after a surge of customer credit card disputes in July, according to the documents seen by Bloomberg.  Each dispute will carry an $8 surcharge, resulting in a nearly $75,000 bill that will hit in September, the documents reportedly said. 

On this news, Hims' stock price fell $2.70 per share, or 7.99%, to close at $31.08 per share on August 24, 2026.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Danielle Peyton
Pomerantz LLP
dpeyton@pomlaw.com
646-581-9980 ext. 7980

View original content to download multimedia:https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-hims--hers-health-inc---hims-302862268.html

SOURCE Pomerantz LLP